Ausgabe 3/2020
Inhalt (26 Artikel)
Creating the “new normal” post-Coronavirus world—web-communication replacing face-to-face interaction
Wolfgang Hilbe, Andreas Pircher, Thorsten Füreder, Holger Rumpold, Eberhard Gunsilius, Rupert Bartsch
Therapies in flux: highlights of the 2019 San Antonio Breast Cancer Symposium (SABCS)
Simon Peter Gampenrieder
Managing an oncology clinic during the COVID-19 pandemic—how we did it in Sarajevo?
Semir Beslija
Fine-tuning front-line therapy in chronic lymphocytic leukemia
Jan-Paul Bohn, Dominik Wolf
Myeloid diseases—Chronic Myeloid Leukemia (CML)—report from ASH 2019 on new developments
Andreas L. Petzer
New systemic treatment options in mycosis fungoides and Sézary syndrome
Magdalena Seidl-Philipp, Van Anh Nguyen
Patient-reported outcomes and psycho-oncological screening in hematology: a practical example of routine electronic monitoring
Jens Lehmann, Lisa M. Wintner, Monika Sztankay, Wolfgang Willenbacher, Roman Weger, Walpurga Weyrer, Gerhard Rumpold, Bernhard Holzner
Comparison of outcomes of two non-BCNU-containing conditioning regimens used in autologous stem cell transplantation for relapsed/refractory lymphoma
Amro Mohamed Sedky El-Ghammaz, Maha El-Zimaity, Afaf Abdel-Aziz Abdel-Ghaffar
Rectal cancer among younger Egyptian patients—clinico-pathological features and oncologic outcomes: A single institution experience
Amir M. Zaid, Engy M. Aboelnaga, Amal Halim, Mohamed Abdelkhalek, Saleh S. Elbalka, Mohamed Zuhdy, Ahmed M. Fareed, Eman M. Ibrahim, Hosam Halim, Islam H. Metwally
Chemoradiotherapy alone or chemoradiotherapy followed by surgery in rectal cancer
Fabian Lunger, Georgios Peros
Neoadjuvant chemoradiotherapy in rectal cancer
Christoph Reinhold Arnold, Julian Mangesius, Robert Jäger, Ute Ganswindt
Circulating tumour DNA-guided adjuvant chemotherapy in colorectal carcinoma
Andreas Reichinger, Holger Rumpold
Four lines of immunochemotherapy combinations in a young patient with an aggressive metastatic colorectal cancer
Frédéric H. Witte, Wolfgang Hilbe, Ercan Müldür
Treatment options in early triple-negative breast cancer
Christoph Suppan, Marija Balic
San Antonio 2019: interesting topics for daily clinical practice in breast cancer
Arik Galid
Biologically effective dose and overall survival in stereotactic body radiotherapy for lung tumors
Osamu Tanaka, Norihiko Funaguchi, Sayaka Toyoshi, Takuya Taniguchi, Kousei Ono, Chiyoko Makita, Masayuki Matsuo